A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection

NCT00089947 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplantation
Graft Rejection

Interventions

DRUG: Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]

Sponsor

Genzyme, a Sanofi Company